Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR DISOPROXIL for Hepatitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 32 adverse event reports in the FDA FAERS database where TENOFOVIR DISOPROXIL was used for Hepatitis.

Most Reported Side Effects for TENOFOVIR DISOPROXIL

Side Effect Reports % Deaths Hosp.
Bone density decreased 10,586 39.2% 159 601
Renal injury 9,255 34.3% 168 490
Skeletal injury 8,320 30.8% 172 490
Chronic kidney disease 7,230 26.8% 215 872
Osteonecrosis 7,182 26.6% 107 427
Bone loss 7,040 26.1% 107 382
Multiple fractures 6,793 25.2% 109 413
Renal failure 6,388 23.7% 264 880
Osteoporosis 5,302 19.7% 73 370
Tooth loss 4,483 16.6% 57 266
Pain 2,929 10.9% 77 404
Emotional distress 2,839 10.5% 71 373
Anxiety 2,600 9.6% 71 425
Anhedonia 2,443 9.1% 57 331
Osteopenia 2,229 8.3% 15 164

Other Indications for TENOFOVIR DISOPROXIL

Hiv infection (19,662) Product used for unknown indication (2,292) Hepatitis b (2,088) Chronic hepatitis b (1,156) Acquired immunodeficiency syndrome (636) Antiretroviral therapy (358) Prophylaxis against hiv infection (142) Hiv test positive (61) Prophylaxis (60) Maternal exposure timing unspecified (58)

Other Drugs Used for Hepatitis

RIBAVIRIN (120) PREDNISONE (90) SOFOSBUVIR (88) MYCOPHENOLATE MOFETIL (80) LEDIPASVIR\SOFOSBUVIR (70) PEGINTERFERON ALFA-2A (64) METHYLPREDNISOLONE (58) ENTECAVIR (49) AZATHIOPRINE (47) TACROLIMUS (44)

Related Pages

TENOFOVIR DISOPROXIL Full Profile All Hepatitis Drugs TENOFOVIR DISOPROXIL Demographics TENOFOVIR DISOPROXIL Timeline